Literature DB >> 8698499

Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

E Konadu1, J Shiloach, D A Bryla, J B Robbins, S C Szu.   

Abstract

Salmonella paratyphi A, the second most common cause of enteric fever in Southeast Asia, is a habitant of and a pathogen for humans only. Lipopolysaccharides (LPS) are both essential virulence factors and protective antigens for systemic infections caused by groups A, B, C, and D nontyphoidal salmonellae. The O-specific polysaccharide of S. paratyphi A is composed of a trisaccharide, -->2-alpha-D)-Manp-(1-->4)-alpha-L-Rhap-(1-->3)-alpha-D-Galp -(1-->, with a branch of D-paratose from the C-3 of alpha-D-mannose, and the C-3 of beta-L-rhamnose is partially O acetylated (C. G. Hellerqvist, B. Lindberg, K. Samuelsson, and A. A. Lindberg, Acta Chem. Scand. 25:955-961, 1971). On the basis of data from our investigational vaccines for enteric bacterial pathogens, including group B salmonellae (D. C. Watson, J. B. Robbins, and S. C. Szu, Infect. Immun. 60:4679-4686, 1992), conjugates composed of the detoxified LPS of S. paratyphi A bound to tetanus toxoid (TT) were prepared by several schemes. LPS was detoxified with acetic acid or with hydrazine; the latter removed O acetyls from the O-specific polysaccharide. The detoxified polysaccharides were activated with cyanogen bromide (CNBr) or with 1-cyano-4-dimethylaminopyridinium tetratfluoroborate (CDAP) and bound to TT with or without a spacer. Solutions of 2.5 microgram of saccharide, alone or as a conjugate, were injected subcutaneously into young mice, and LPS and TT antibodies were measured by enzyme-linked immunosorbent assaying. A conjugate synthesized with higher-molecular-weight O-SP elicited the highest anti-LPS levels. Only conjugates with O acetyls elicited serum immunoglobulin G anti-LPS with bactericidal activity. There were no statistically significant differences between LPS antibody levels elicited by conjugates synthesized with or without a spacer. The conjugate with O-specific polysaccharide activated by CDAP and bound to TT without a spacer elicited the highest level of TT antibodies. Clinical evaluation (if S. paratyphi A conjugates is planned.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698499      PMCID: PMC174130          DOI: 10.1128/iai.64.7.2709-2715.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Multidrug-resistant typhoid in children: presentation and clinical features.

Authors:  Z A Bhutta; S H Naqvi; R A Razzaq; B J Farooqui
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct

2.  Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb. nov.

Authors:  M W Reeves; G M Evins; A A Heiba; B D Plikaytis; J J Farmer
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

3.  Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

Authors:  K P Klugman; I T Gilbertson; H J Koornhof; J B Robbins; R Schneerson; D Schulz; M Cadoz; J Armand
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

4.  Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.

Authors:  C H Simanjuntak; F P Paleologo; N H Punjabi; R Darmowigoto; H Totosudirjo; P Haryanto; E Suprijanto; N D Witham; S L Hoffman
Journal:  Lancet       Date:  1991-10-26       Impact factor: 79.321

5.  From the national institutes of health. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the enterobacteriaceae and other bacteria.

Authors:  F Orskov; I Orskov
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

6.  Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects.

Authors:  A DeMaria; M A Johns; H Berberich; W R McCabe
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

7.  A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.

Authors:  C C Peeters; A M Tenbergen-Meekes; D E Evenberg; J T Poolman; B J Zegers; G T Rijkers
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

8.  Relation between structure and immunologic properties of the Vi capsular polysaccharide.

Authors:  S C Szu; X R Li; A L Stone; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Multi-drug resistance in salmonellae isolated from enteric fever cases at Porur--a semi urban area near Madras City.

Authors:  S L Verghese; R Manonmani; S Balasubramanian; S Chandrasekharan
Journal:  J Commun Dis       Date:  1992-03

10.  Intragenic recombination in a flagellin gene: characterization of the H1-j gene of Salmonella typhi.

Authors:  G Frankel; S M Newton; G K Schoolnik; B A Stocker
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  34 in total

1.  Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Authors:  Vladimir A Ledov; Marina E Golovina; Anna A Markina; Yuriy A Knirel; Vyacheslav L L'vov; Alexander L Kovalchuk; Petr G Aparin
Journal:  Vaccine       Date:  2019-01-19       Impact factor: 3.641

2.  A scalable method for O-antigen purification applied to various Salmonella serovars.

Authors:  F Micoli; S Rondini; M Gavini; I Pisoni; L Lanzilao; A M Colucci; C Giannelli; F Pippi; L Sollai; V Pinto; F Berti; C A MacLennan; L B Martin; A Saul
Journal:  Anal Biochem       Date:  2012-11-07       Impact factor: 3.365

Review 3.  Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Authors:  Raphael Simon; Myron M Levine
Journal:  Hum Vaccin Immunother       Date:  2012-02-28       Impact factor: 3.452

4.  Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.

Authors:  Aamir Ali; So J An; Changfa Cui; Abdul Haque; Rodney Carbis
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

5.  Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.

Authors:  E Konadu; A Donohue-Rolfe; S B Calderwood; V Pozsgay; J Shiloach; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Evaluation of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin.

Authors:  Z Kossaczka; S C Szu
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

7.  Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.

Authors:  Raphael Simon; Sharon M Tennant; Jin Y Wang; Patrick J Schmidlein; Andrew Lees; Robert K Ernst; Marcela F Pasetti; James E Galen; Myron M Levine
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

8.  The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Authors:  Vu Dinh Thiem; Feng-Ying C Lin; Do Gia Canh; Nguyen Hong Son; Dang Duc Anh; Nguyen Duc Mao; Chiayung Chu; Steven W Hunt; John B Robbins; Rachel Schneerson; Shousun C Szu
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

9.  Syntheses of Salmonella Paratyphi A Associated Oligosaccharide Antigens and Development towards Anti-Paratyphoid Fever Vaccines.

Authors:  Debashis Dhara; Scott M Baliban; Chang-Xin Huo; Zahra Rashidijahanabad; Khandra T Sears; Setare Tahmasebi Nick; Anup Kumar Misra; Sharon M Tennant; Xuefei Huang
Journal:  Chemistry       Date:  2020-10-22       Impact factor: 5.236

10.  Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.

Authors:  Zhigang Jin; Chiayung Chu; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.